Symbols

SCNX

Scienture Holdings·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About SCNX

Scienture Holdings, Inc.

A comprehensive health services and pharmaceutical product company

Industry

Pharmaceutical

Established Date

07/15/2005

Listing Date

02/13/2020

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.scientureholdings.com

Security Type

Common stock

Office address

20 Austin Blvd, Commack, NY 11725

Business

Introduction

Science Holdings, Inc., was incorporated in Delaware on July 15, 2005. The company's main operating subsidiary is Science, LLC. Science LLC is a specialty pharmaceutical company focused on the commercialization and development of products for the treatment of cardiovascular (" CVS ") and central nervous system (" CNS ") diseases.

Company Financials

EPS

SCNX has released its 2025 Q2 earnings. EPS was reported at -0.48, versus the expected 0, missing expectations. The chart below visualizes how SCNX has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

SCNX has released its 2025 Q4 earnings report, with revenue of -168.70K, reflecting a YoY change of -417.80%, and net profit of -28.12M, showing a YoY change of -292.59%. The Sankey diagram below clearly presents SCNX's revenue sources and cost distribution.